tbuckley/cabot-search huggingface dataset:
Gasoline Ingestion
Authors: Wendy Klein Schwartz
Journal: JAMA (1979)

<h3>To the Editor.—</h3> Although hydrocarbon ingestion is a frequent cause of poisoning in children in the United States, ingestion of hydrocarbons by adults is relatively uncommon. However, with the present gasoline shortage, the incidence of gasoline ingestion by adults has greatly increased. A similar situation occurred during the fuel shortage in 1974.<sup>1</sup>These ingestions are the result of swallowing one to two mouthfuls of gasoline during the process of siphoning. The Maryland Poison Information Center normally receives fewer than one call per day involving a gasoline exposure. In 1978 there was a total of 235 gasoline-related calls. During the month of June 1979, a total of 239 calls concerning gasoline were received, 225 of which involved oral exposures (183 adults, 42 children). Gasoline ingestion represented 10% of that month's calls, compared with only 1% in 1978. The increase in gasoline-related calls was most dramatic toward the end of the
Papular Mucinosis
Authors: Charles M. Shapiro
Journal: JAMA (1970)

The thickened skin with papules and plaques of a patient with papular mucinosis is explained by focal accumulations of hyaluronic acid and fibroblastic proliferation in the dermis. Findings from protein analysis demonstrated an associated aberration in protein production that appears to be characteristic of this disease: an abnormal peak in the position beyond that of γ-globulin on serum protein electrophoresis and immunologic studies which shows the γ-globulin to be IgG with only L type light chains. The etiology is unknown, but the condition may represent an immunologic response to an unknown antigenic stimulus.
Availability of Histoplasmosis Prevention Guidelines
Journal: JAMA (1997)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
JAMA Internal Medicine
Authors: Phil Fontanarosa, Annette Flanagin, Brenda Gregoline, Lauren Fischer, John Mcfadden, Donald Smith, Karen Boyd, Rochelle Lodder, Diane Cannon, Connie Manno, Fred Marshall, Laura Copyreaders, Catherine Adamczyk, Stephanie Alden, Jan Beckmeyer, Mary Clavey, Roya Coerver-Connolly, Laura Khatiblou, Juliann King, Donna Tarsney, Caroline Thordsen, Wanda Assistant, Larry Bryant, Monica Mungle, Elaine Managers, Staff Gardner- Gullens, Fanny Brown, Paul Frank, Rachell Lozano, Michaela Mark, Kathryn Muskovich, Kate Pezalla, Gale Saulsberry, Michael Berkwits, Michelle Kurzynski, Eric Butkus, Christopher Hastings, Craig Mccaffrey, Reuben Rios, Ronna Henry, Joshua Bird, Alison Burke, Cassio Lynm, David Song, Deputy Livingston, Thomas Cole, Marla Hall, Deanna Willis, Yolanda Davis, Joseph Thornton, Preeti Malani, Deanna Bellandi, Jim Periodical, Thomas Staff, Monica Smith, Jeffery Bonistalli Manager, Kathy Russell, Mirna Monal, Stacey Mchugh, Tim Melroy Classified, Thalia Moss, Susan Henning, Mark Thornbury, Tricia Castellano, Saskia Bolore, Gretchen Linder, Brian Mccartney, David Baum, Rebecca Haas, Christine Hearne, Irma Lara, Audra Lawlor, Matt Herron, Elizabeth Solaro, Geoffrey Flick, Paul Gee Managers, Rick Bell, Michael Mcgraw, Sara Nagy, Stacy Staff, Millette Jackson-Bates, Karen Adams-Taylor, Karl Elvin, Sue Sherrill, Brian Shields Managers, David Antos, Chris Borden, Debbie Camp, Lydia Cruz, Diane Darnell, Colleen Kelly, Chris Meyer, Jaye Mize, Annemarie Neff, J Neff, Sean O'donnell, Sean Ohlson, Phil O'leary, Susan Price, Denise Steinhauser, Production Services, Kim Boler, Rhonda Brown, Timothy Burke, Daniel Degroot, Jordynn Farrar, Euwanaha Joiner-Smith, Cindy Rendlen, Ellen Yoshihara, Circulation Services, Julie Burton, Dexter Golden, Erin Hinchcliff, Noemi Rivera, Geneine Van, Someren Composition, New Media, Gail Barrett, Regina Brownlee, Amanda Camino, Brenda Chandler- Grayer, Scott Curl, Amy Evers, Teri Hutchison, Mary Kuranda, Joshua Lampinen, Patricia Panek, La Son, Diggs Sledge, George Thomson Graphics, Joe Amft, Maria Duda, Fred Furtner, Carolyn Hall, Maria Kowalkowski, Proofreading Carol, Joy Farrell, Daniel James, Judith Literskis, Teresa Omiotek, James Madara, Bernard Hengesbaugh, Jeffrey Tabas, San Francisco, Paul Varosy, Gregory Marcus, Nora Goldschlager, California Cme, Rebecca Larson, Deborah Grady, Rosemary Gibson, Virginia Arlington, Mitchell Katz, Los Angeles, Patrick California, David Glidden, John Neuhaus, Kenneth Covinsky, Joseph Ross, New Haven, Raman Khanna, Kathleen Mckibbin, Katherine Gilhooley, Mary Kohut, Howard Bauchner, Rita Redberg, Shannon Brownlee, Tanner Caverly, Ann Arbor, Brandon Combs, Christopher Moriates, Neel Shah, Robert Steinbrook, Connecticut Web, Judyann Bigby, Ezekiel Emanuel, Mark Feinglos, Chi-Yuan Hsu, Kurt Kroenke, Grace Lin, Mary Mcdermott, C Noel, Bairey Merz, Samia California, Robert Phillips, Michael Pignone, Chapel Hill, North Carolina, Judith Prochaska, Kathryn Rexrode, Mary Tinetti, Nicolas Rodondi, Iona Heath
Journal: JAMA Internal Medicine (2014)
Fatal carbon monoxide poisoning at a motel
Authors: M. Wharton
Journal: JAMA (1989)

One man died and four other persons required hospitalization following accidental exposure to carbon monoxide at a motel. In spite of prompt diagnosis of the index cases, a search for the source of exposure and for other possible victims was delayed more than ten hours. Subsequent investigation revealed that air conditioning units drew carbon monoxide from the gas heaters for the motel's indoor swimming pools into three adjacent guest rooms through structural defects in the walls. Emergency care providers must remember that in environmental exposures, other persons may continue to be at risk, and efforts must be made to identify them. (<i>JAMA</i>1989;261:1177-1178)
'Saddle Block' in Toxemia Supported
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Neoplastic Diseases
Authors: James F. Holland
Journal: JAMA (1984)

The disorganization of multicellular architecture and function that constitutes a cancer is, although abnormal, not wholly chaotic. Specific genes determine the cancerous behavior of affected cells. In cancer-associated retroviruses the specific genes are called "viral oncogenes," and they seem, because of similar deoxynucleotide sequences that are demonstrable in the chromosomal complement of normal cells, to have been acquired from progenitor cellular oncogenes (c-oncogenes). C-oncogenes have been preserved throughout evolution, since near-identical sequences are found in vertebrates from fish to man, and some are even found in fruit flies and worms. This suggests that c-oncogenes likely determine important unidentified functions in normal cells. C-oncogenes in tumors may be activated from the protooncogene state by insertion of viral genes nearby, in the absence of a viral oncogene, or by a chemical carcinogen. The gene product in the cancer cell may be a normal molecule in excess or, because of substitution of a
Reply to Marco Borghesi, Gaetano La Manna, and Riccardo Schiavina's Letter to the Editor re: Sabine D. Brookman-May, Matthias May, Ingmar Wolff, et al. Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1–pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA Project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors? Eur Urol 2015;67:943–51
Authors: Sabine Brookman-May, Shahrokh F. Shariat, Matthias May
Journal: European Urology (2015)
Free-Radical Metabolites of Acetaminophen and a Dimethylated Derivative
Authors: Volker Fischer, Paul R. West, Laura S. Harman, Ronald P. Mason
Journal: Environmental Health Perspectives (1985)

The oxidation of acetaminophen (4'-hydroxyacetanilide) to the corresponding N-acetyl-p-benzoquinone imines by plant and mammalian peroxidases is discussed. The acetaminophen free radical (N-acetyl-4-aminophenoxyl) has been reported as an intermediate. It is very reactive and forms melanin-like polymeric products. Application of a fast-flow system makes it possible to detect the transient species and clearly distinguish it from persistent paramagnetic melanin polymers. A model system, leading to more stable metabolites, can be obtained by introduction of methyl groups next to the oxygen, 3',5'-dimethylacetaminophen (3',5'-dimethyl-4'-hydroxyacetanilide). The ESR spectrum of the free radical formed could be completely analyzed and confirmed by deuterium substitution. The data are consistent with the assignment to a phenoxyl free radical (N-acetyl-2,6-dimethyl-4-amino-phenoxyl). Its formation is discussed in terms of substrate, hydrogen peroxide and enzyme concentration dependence. It is believed to be formed via a direct one-electron oxidation of 3',5'-dimethyl-4'-hydroxy-acetanilide. The radical does not form polymers or react with nucleophiles. Its redox behavior is discussed. The possible reaction of these phenoxyl free radicals with oxygen is thought to be negligible.
Incorrect Numbering of Reference Citations and Incorrect Wording in Figure Legend.
Journal: JAMA (1992)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE PAINS OF TABES.
Journal: JAMA (1905)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Scottish News
Authors: John Lister
Journal: New England Journal of Medicine (1970)

ALTHOUGH the health services in Scotland are broadly the same as those in England and Wales, they are separately administered by the Scottish Home and Health Department. During a visit to Scotland last summer it was interesting to read of their problems in the Scottish newspapers. There were several familiar topics under discussion at the time. The Western Regional Hospital Board, which covers Glasgow, was appealing to the Government for more money to offset the declining purchasing power of the pound. Reporting on last year's accounts, the chairman of the Board's finance committee said that although more had been spent . . .
Abstract 137: Efficacy Of Raise Protocol For Children With Incomplete Kawasaki Disease
Authors: Kazuyuki Naoi, Yuji Asami, Shinichi Takatsuki, Mitsuru Seki, Satoshi Ikehara, Tomotaka Nakayama, Hiroyuki Matsuura, Tohru Kobayashi, Hirokazu Arakawa, Tsutomu Saji
Journal: Circulation (2015)

Background: Although RAISE study demonstrated that intravenous immunoglobulins (IVIG) plus prednisolone (PSL) therapy for refractory Kawasaki disease (KD) reduced coronary artery aneurysm, the study population included a few incomplete KD. The aim of study was to evaluate the efficacy of RAISE protocol for incomplete KD. Methods: Children with incomplete KD which have 4 or less major symptoms of KD were enrolled. Using Kobayashi score, children were divided into low and high risk for IVIG resistance. Children with low risk group received IVIG monotherapy, whereas IVIG plus PSL therapy administrated for high risk group. Retrospectively, we assessed initial treatment response and coronary artery abnormalities (CAAs). Results: Overall, 63 incomplete KD (age; median and range 17 months (1-115 months), sex ratio; boys:girls 37:26) were enrolled. Median day of illness at diagnosis was 5 day of illness (2-10 days). Low risk group included 52 cases (83%) and the remaining 11 cases were high risk group. In low risk group, 87% of children (45 cases) were initial treatment responders. All 7 non-responders were responded to additional methylprednisolone steroid pulse therapy. All 11 children with high risk group were responders to the initial treatment. Five cases have equal to greater than 2.5 of Z-Score, which were all low risk group. All CAAs regressed to normal coronary diameter within 1 month. Conclusions: RAISE protocol was useful for the treatment of incomplete KD without any CAAs.
VITAL STATISTICS AND REGISTRATION OF BIRTHS.
Journal: JAMA (1901)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Diagnosis of Torulopsis glabrata infection. Successful treatment of two cases
Authors: H. Hahn
Journal: JAMA (1968)

Two patients with<i>Torulopsis glabrata</i>fungemia were cured. One, an elderly man with cancer, diabetes, and<i>Pseudomonas</i>urinary tract infection, had received many antibiotics. His cure was attributed to amphotericin B therapy. The other patient was pregnant, and the source of the fungemia was never detected; her cure was associated with the termination of pregnancy. With this method of laboratory identification of<i>T glabrata</i>and increased awareness of the potential pathogenicity of the so-called opportunistic fungi on the part of both the clinical microbiologist and the clinician, more cases of<i>T glabrata</i>infection will be recognized, particularly among patients who are debilitated or who have altered host defenses.
Thrombophlebitis in systemic lupus erythematosus
Authors: B. Peck
Journal: JAMA (1978)

Thrombophlebitis occurred in 14 (12.2%) of 114 patients with active systemic lupus erythematosus (SLE). Abnormal clotting occurred despite the presence of thrombocytopenia or circulating anticoagulants in some of the patients, and the development of pulmonary emboli was verified in seven. Although infrequently reported, the association of thrombophlebitis with active SLE is apparently not uncommon. While there were no features that distinguished this group of patients from other groups of patients with SLE, there are some possible mechanisms. Recognition of this complication of SLE is important because of the frequent occurrence of SLE-induced pleuritis and its similarity to the pain of pulmonary emboli. (<i>JAMA</i>240:1728-1730, 1978)
Utility of the Prostate-specific Antigen Test
Authors: Steven H. Woolf
Journal: Annals of Internal Medicine (1994)

Letters15 June 1994Utility of the Prostate-specific Antigen TestSteven H. Woolf, MD, MPHSteven H. Woolf, MD, MPHMedical College of Virginia; Richmond, VA 23298Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-120-12-199406150-00033 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The article by Kramer and colleagues was excellent, but I found the accompanying editorial inaccurate and misleading. Dr. Walsh argued that prostate screening tests are diagnostic because “75% of men older than 50 years have symptoms.” He based this claim on his own book [1], in which he cited an estimate of the 40-year period prevalence for prostatic hypertrophy [2]. Period prevalence is an inappropriate measure of pretest probability. A more meaningful measure would be the point prevalence, which is about 3.5% for men older than 65 years [3]. The bias of a referral urology practice may ...References1. Walsh PC. Benign prostatic hyperplasia. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED Jr, eds. Campbell's Urology. 6th ed. Philadelphia: W.B. Saunders; 1992:1009. Google Scholar2. Glynn RJ, Campion EW, Bouchard GR, Silbert JE. The development of benign prostatic hyperplasia among volunteers in the normative aging study. Am J Epidemiol. 1985; 121:78. Google Scholar3. Adams PF, Benson V. Current estimates from the National Health Interview Survey, 1991. Vital Health Stat 10(184). Hyattsville, MD: National Center for Health Statistics; 1991. Google Scholar4. Adolfsson J, Steineck G, Whitmore WF Jr. Recent results of management of palpable clinically localized prostatic cancer: a review and commentary. Cancer. 1993; 72:310-22. Google Scholar5. Fontana RS, Sanderson DR, Taylor WF, Woolner LB, Miller WE, Muhm JR, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis. 1984; 130:561-5. Google Scholar Author, Article, and Disclosure InformationAffiliations: Medical College of Virginia; Richmond, VA 23298 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPart II. Prostate cancer screening 15 June 1994Volume 120, Issue 12Page: 1053-1054KeywordsBenign prostatic hyperplasiaCase seriesCell biologyClinical trialsHealth careLung and intrathoracic tumorsProstate diseasesRadical prostatectomySputumUrology ePublished: 15 August 2000 Issue Published: 15 June 1994 Copyright & PermissionsCopyright © 1994 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
PROS AND CONS OF FOURIER ANALYSIS OF MULTI-GATED CARDIAC STUDIES.
Authors: R. E. Wendt, P. H. Murphy, J. W. Clark, J. A. Burdine
Journal: Clinical Nuclear Medicine (1983)

Department of Electrical Engineering, Rice University, and Department of Radiology, Baylor College of Medicine, and Nuclear Medicie Service, St. Luke's Episcopal -Texas Children's Hospitals and Texas Heart Institute, Houston, TX.
Nuclear medicine
Authors: N. P. Alazraki
Journal: JAMA (1995)

Clinical nuclear medicine continues to advance, metamorphose, and develop new approaches to diagnosis and therapy. In the past year, the most notable advances were in cardiac nuclear medicine, imaging cancer, infection, computer and instrumentation refinements for positron emission tomography (PET) and single photon emission computed tomography (SPECT), refinements in renal functional analysis, and continued clinical documentation of the value of PET imaging. Food and Drug Administration (FDA) approval of radiopharmaceuticals, marking clinical availability of new agents for all patients in the United States, is always big news in nuclear medicine. In 1994, we saw approval of the indium In 111—labeled somatostatin receptor binding agent, indium In 111 pentetreotide (Octreoscan, Mallinckrodt Inc), for imaging neuroendocrine tumors, technetium Tc 99m bicisate (Neurolite, DuPont Merck Inc) for cerebral perfusion imaging in patients with strokes, and fludeoxyglucose F 18 (formerly known as fluorodeoxyglucose F 18) for imaging metabolic alterations in the brain in patients